Literature DB >> 25573988

Colony stimulating factor-1 receptor signaling networks inhibit mouse macrophage inflammatory responses by induction of microRNA-21.

Cristina I Caescu1, Xingyi Guo2, Lydia Tesfa3, Tushar D Bhagat1, Amit Verma1, Deyou Zheng4, E Richard Stanley1.   

Abstract

Macrophage polarization between the M2 (repair, protumorigenic) and M1 (inflammatory) phenotypes is seen as a continuum of states. The detailed transcriptional events and signals downstream of colony-stimulating factor 1 receptor (CSF-1R) that contributes to amplification of the M2 phenotype and suppression of the M1 phenotype are largely unknown. Macrophage CSF-1R pTyr-721 signaling promotes cell motility and enhancement of tumor cell invasion in vitro. Combining analysis of cellular systems for CSF-1R gain of function and loss of function with bioinformatic analysis of the macrophage CSF-1R pTyr-721-regulated transcriptome, we uncovered microRNA-21 (miR-21) as a downstream molecular switch controlling macrophage activation and identified extracellular signal-regulated kinase1/2 and nuclear factor-κB as CSF-1R pTyr-721-regulated signaling nodes. We show that CSF-1R pTyr-721 signaling suppresses the inflammatory phenotype, predominantly by induction of miR-21. Profiling of the miR-21-regulated messenger RNAs revealed that 80% of the CSF-1-regulated canonical miR-21 targets are proinflammatory molecules. Additionally, miR-21 positively regulates M2 marker expression. Moreover, miR-21 feeds back to positively regulate its own expression and to limit CSF-1R-mediated activation of extracellular signal-regulated kinase1/2 and nuclear factor-κB. Consistent with an anti-inflammatory role of miRNA-21, intraperitoneal injection of mice with a miRNA-21 inhibitor increases the recruitment of inflammatory monocytes and enhances the peritoneal monocyte/macrophage response to lipopolysaccharide. These results identify the CSF-1R-regulated miR-21 network that modulates macrophage polarization.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25573988      PMCID: PMC4335087          DOI: 10.1182/blood-2014-10-608000

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  107 in total

Review 1.  Negative receptor signalling.

Authors:  Ivan Dikic; Silvia Giordano
Journal:  Curr Opin Cell Biol       Date:  2003-04       Impact factor: 8.382

Review 2.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 3.  Colony-stimulating factor-1 in immunity and inflammation.

Authors:  Violeta Chitu; E Richard Stanley
Journal:  Curr Opin Immunol       Date:  2005-12-06       Impact factor: 7.486

4.  Phase I trial of a B7-1 (CD80) gene modified autologous tumor cell vaccine in combination with systemic interleukin-2 in patients with metastatic renal cell carcinoma.

Authors:  Scott J Antonia; John Seigne; Jose Diaz; Carlos Muro-Cacho; Martine Extermann; Mary Jane Farmelo; Maria Friberg; Marwan Alsarraj; J J Mahany; Julio Pow-Sang; Alan Cantor; William Janssen
Journal:  J Urol       Date:  2002-05       Impact factor: 7.450

Review 5.  MicroRNA-mediated control of macrophages and its implications for cancer.

Authors:  Mario Leonardo Squadrito; Martin Etzrodt; Michele De Palma; Mikael J Pittet
Journal:  Trends Immunol       Date:  2013-03-13       Impact factor: 16.687

6.  Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21.

Authors:  Frederick J Sheedy; Eva Palsson-McDermott; Elizabeth J Hennessy; Cara Martin; John J O'Leary; Qingguo Ruan; Derek S Johnson; Youhai Chen; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2009-11-29       Impact factor: 25.606

Review 7.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

Review 8.  The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications.

Authors:  T Weichhart; M D Säemann
Journal:  Ann Rheum Dis       Date:  2008-12       Impact factor: 19.103

9.  B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum.

Authors:  L Chen; P McGowan; S Ashe; J V Johnston; I Hellström; K E Hellström
Journal:  Cancer Res       Date:  1994-10-15       Impact factor: 12.701

10.  Validation of miRNA-mRNA interactions by electrophoretic mobility shift assays.

Authors:  Anna Solé; Núria Mencia; Xenia Villalobos; Véronique Noé; Carlos J Ciudad
Journal:  BMC Res Notes       Date:  2013-11-12
View more
  64 in total

1.  Potentiating vascular-targeted photodynamic therapy through CSF-1R modulation of myeloid cells in a preclinical model of prostate cancer.

Authors:  Souhil Lebdai; Mathieu Gigoux; Ricardo Alvim; Alexander Somma; Karan Nagar; Abdel Rahmene Azzouzi; Olivier Cussenot; Taha Merghoub; Jedd D Wolchok; Avigdor Scherz; Kwanghee Kim; Jonathan Coleman
Journal:  Oncoimmunology       Date:  2019-03-28       Impact factor: 8.110

Review 2.  Role of the macrophage in HIV-associated neurocognitive disorders and other comorbidities in patients on effective antiretroviral treatment.

Authors:  Jay Rappaport; David J Volsky
Journal:  J Neurovirol       Date:  2015-05-02       Impact factor: 2.643

Review 3.  Emerging role of microRNAs in regulating macrophage activation and polarization in immune response and inflammation.

Authors:  Xiao-Qin Wu; Yao Dai; Yang Yang; Cheng Huang; Xiao-Ming Meng; Bao-Ming Wu; Jun Li
Journal:  Immunology       Date:  2016-04-27       Impact factor: 7.397

Review 4.  Emerging Roles for CSF-1 Receptor and its Ligands in the Nervous System.

Authors:  Violeta Chitu; Şölen Gokhan; Sayan Nandi; Mark F Mehler; E Richard Stanley
Journal:  Trends Neurosci       Date:  2016-04-12       Impact factor: 13.837

Review 5.  MicroRNA regulation of macrophages in human pathologies.

Authors:  Yuanyuan Wei; Andreas Schober
Journal:  Cell Mol Life Sci       Date:  2016-05-02       Impact factor: 9.261

Review 6.  miRNA in Macrophage Development and Function.

Authors:  Sashwati Roy
Journal:  Antioxid Redox Signal       Date:  2016-08-19       Impact factor: 8.401

7.  inv(16) and NPM1mut AMLs engraft human cytokine knock-in mice.

Authors:  Jana M Ellegast; Philipp J Rauch; Larisa V Kovtonyuk; Rouven Müller; Ulrich Wagner; Yasuyuki Saito; Nicole Wildner-Verhey van Wijk; Christine Fritz; Anahita Rafiei; Veronika Lysenko; Ewa Dudkiewicz; Alexandre P Theocharides; Davide Soldini; Jeroen S Goede; Richard A Flavell; Markus G Manz
Journal:  Blood       Date:  2016-08-31       Impact factor: 22.113

8.  Drainage of inflammatory macromolecules from the brain to periphery targets the liver for macrophage infiltration.

Authors:  Linlin Yang; Jessica A Jiménez; Alison M Earley; Victoria Hamlin; Victoria Kwon; Cameron T Dixon; Celia E Shiau
Journal:  Elife       Date:  2020-07-31       Impact factor: 8.140

Review 9.  MiRNA-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response.

Authors:  Kobina Essandoh; Yutian Li; Jiuzhou Huo; Guo-Chang Fan
Journal:  Shock       Date:  2016-08       Impact factor: 3.454

10.  Exosomes as Part of the Human Adipose-Derived Stem Cells Secretome- Opening New Perspectives for Cell-Free Regenerative Applications.

Authors:  Alexandra Dobranici; Ramona Tecucianu; Sorina Dinescu; Aida Selaru; Roxana Balahura; Simona Ignat; Marieta Costache
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.